Clin2
NCT06327581Possibly a fitRecruiting

Microneedling with creams for patchy hair loss

Alopecia Areata

Treatments studied

Part of Skin clinical trials.

This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
88 people
Ages
16 years and older
Study type
Interventional

Who can take part

  • You are 16 years or older
  • You have one or more bald patches on your scalp, each no bigger than 6 cm (about 2.4 inches) across
  • You have not used any hair loss treatments (pills or creams) in the last 3 months
  • You are not pregnant or breastfeeding
  • You are willing to attend several visits and sign a consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07453238Not yet recruiting· Phase 4
Comparing two creams for patchy hair loss

This study compares two treatments for patchy hair loss on the scalp: a vitamin D-like cream (calcipotriol) and steroid injections (intralesional steroids). It aims to see which is more effective at regrowing hair in adults with less than half of the scalp affected.

NCT07459933Not yet recruiting· Phase 4
Comparing two topical treatments for patchy hair loss

This study tests whether a methotrexate lotion or minoxidil lotion is better at regrowing hair in people with patchy hair loss on the scalp. You will use one of the treatments for a period of time, and the doctors will check your progress.

NCT07803874Recruiting
UV light skin imaging for patchy hair loss

This study uses a special UV light to look at your scalp in a new way. It may help doctors better understand and monitor alopecia areata (a condition that causes patchy hair loss). Participation involves only imaging, no drugs or invasive procedures.

Istanbul
NCT06012240Recruiting· Phase 3
Testing Upadacitinib for Severe Alopecia Areata

This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.

Birmingham, Alabama
NCT07311564Recruiting· Phase 2
Study of LAD603 for adults with severe alopecia areata

This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.

Omaha, Nebraska
NCT07533006Recruiting· Phase 2
Study of a new treatment for severe hair loss

This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.

Fremont, California

Hear when a new Alopecia Areata trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.